Lipid-independent effects of an estrogen-statin combination: Inhibition of expression of adhesion molecules and plasminogen activator inhibitor-I in human endothelial cell cultures

Climacteric

Volumn 4, Issue 3, 2001, Pages 209-214

  Seeger, H ^a   Wallwiener, D ^a   Mueck, A O ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cell adhesion molecules; Estradiol; Fluvastatin; Plasminogen activator inhibitor 1

Indexed keywords

ANTILIPEMIC AGENT; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; ESTROGEN; FLUINDOSTATIN; INTERCELLULAR ADHESION MOLECULE 1; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM CELL; GENE EXPRESSION; HEART PROTECTION; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034823214     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.4.3.209.214     Document Type: Article

References (28)

1. Estrogen replacement therapy and coronary artery disease
2. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
3. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women
4. Concurrent use of simvastatin and estrogen-progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women
5. Hormone replacement therapy and simvastatin in the therapy of hypercholesterolemic postmenopausal women
6. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary heart diesease
7. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women
8. Regulatory mechanisms of the vascular endothelium: An update
9. Role of endothelial dysfunction in coronary disease
10. The protective effects of estrogen on the cardiovascular system
11. Statins do more than just lower cholesterol
12. The role of adhesion molecules in atherosclerosis
13. Plasma concentration of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men
14. Role of estrogen in endothelial cell behaviour
15. Modulation of cellular adhesion molecules and endothelial nitric oxide synthase by estrogen
16. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal women
17. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease
18. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: Role of nitric oxide
19. Plasminogen-activator inhibitor type 1 and coronary artery disease
20. Effects of hormone replacement therapy on fibrinolysis in postmenopausal women
21. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but increases tissue type plasminogen activator in cultured human endothelial cells
22. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells
23. Postprandial effects of gemfibrozil vs. simvastatin in hypercholesteremic subjects with borderline hypertriglyceridemia
24. Fluvastatin - A review of its pharmacology and use in management of hypercholesterolaemia
25. Effect of fluvastatin and estradiol on the production of prostacyclin and endothelin in human umbilical vein endothelial cells
26. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) study
27. Hormone replacement therapy and increased plasma concentrations of C-reactive protein